NorthWest Biotherapeutics Inc (NWBO)

[JerryCampbell]

You're wrong, about pretty much everything I think.

Downlisting was nwbo's choice, but only in the sense that they "chose" right before NASDAQ was going to force them out for repeatedly violating financing rules.

I don't believe the nefarious forces argument. Or the naked shorting claims.

nwbo is a company with zero prior experience getting FDA approval. They've blundered repeatedly due to lack of experience. Some of that is CEO hubris, like believing that all big pharma could contribute was cash. She has consistently underestimated the time, cost, and difficulty.

It has everything to do with treating patients, generating revenue, and funding other research.

1) Isn't treating patients the end goal? Assuming nwbo gets approval (not a safe assumption in my view), the sooner it happens the sooner they can give GBM patients another option.

2) Generating revenue is the life blood of companies.

3) If you believe the bull case, then getting Direct off the shelf should be important to you.